Nav: Home

Springer adds Journal of Neurodevelopmental Disorders to biomedical journal portfolio

October 27, 2008

Springer is launching the Journal of Neurodevelopmental Disorders to complement its portfolio of biomedical journals. Published quarterly, it will be available in both online and print formats beginning March 2009. Target audiences will include both researchers and clinicians interested in an integrated, interdisciplinary perspective on the pathogenesis and treatment of neurodevelopmental disorders.

The Journal of Neurodevelopmental Disorders is aimed at integrating current, cutting-edge research across a number of disciplines − neurobiology, genetics, cognitive neuroscience and psychology − and disorders. The primary focus will be on pathogenesis: that is, the study of the origin and development of a disease or disorder. Treatment studies which lead to new insights about the pathogenesis of neurodevelopmental disorders will be relevant subjects for this publication. An international editorial board will support Editor-in-Chief Dr. Joseph Piven of the University of North Carolina at Chapel Hill.

Ann Avouris, Editor, Neuroscience, at Springer, said, "I am proud to welcome the journal into our portfolio of groundbreaking publications in translational research. The Journal of Neurodevelopmental Disorders will support and promote interdisciplinary research into such disorders as autism, Fragile X Syndrome and tuberous sclerosis, helping to bridge the gap between basic research and treatment in these critical areas."

Dr. Joseph Piven, Editor-in-Chief, said, "Progress in understanding the pathogenesis of complex neurodevelopmental disorders will require an interdisciplinary perspective that juxtaposes a number of disorders to tease apart common and unique aspects of their phenomenology and underlying mechanisms. The Journal of Neurodevelopmental Disorders will provide a forum for this research."

The Journal of Neurodevelopmental Disorders will be available in print and on Springer's online platform www.springerlink.com. All articles will be published online via Online First™ before they appear in print, thereby ensuring rapid dissemination of papers to the scientific community. The journal will include Cross Reference Linking and ToC Alerts, a feature by which subscribers receive the table of contents by email weeks in advance of the new issue. All authors, via the Springer Open Choice™ program, will have the option of publishing their articles using the open access publishing model.
-end-
Springer (www.springer.com) is the second-largest publisher of journals in the science, technology, and medicine (STM) sector and the largest publisher of STM books. Springer is part of Springer Science+Business Media, one of the world's leading suppliers of scientific and specialist literature. The group publishes over 1,700 journals and more than 5,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in over 20 countries in Europe, the USA, and Asia, and some 5,000 employees.

Journal of Neurodevelopment Disorders ISSN: 1866-1947 (print version) ISSN: 1866-1955 (electronic version)

Springer

Related Neurodevelopmental Disorders Articles:

CBD may alleviate seizures, benefit behaviors in people with neurodevelopmental conditions
A marijuana plant extract, also known as cannabidiol (CBD), is being commonly used to improve anxiety, sleep problems, pain, and many other neurological conditions.
Is pollution linked to psychiatric disorders?
Researchers are increasingly studying the effects of environmental insults on psychiatric and neurological conditions, motivated by emerging evidence from environmental events like the record-breaking smog that choked New Delhi two years ago.
Finding a cause of neurodevelopmental disorders
Neurodevelopmental disorders arising from rare genetic mutations can cause atypical cognitive function, intellectual disability, and developmental delays, yet it is unclear why and how this happens.
Genes underscore five psychiatric disorders
A group of international doctors has uncovered the genes that contribute to the development of ADHD, autism spectrum disorder, bipolar disorder, major depression and schizophrenia.
New compounds could be used to treat autoimmune disorders
In autoimmune disorders, the body's defense system erroneously attacks normal cells, leading to serious health problems.
Neurodevelopmental disorders may be rooted in genetics and mitochondrial deficits
A new study published in Neuron provides the first evidence showing that individual nerve cells fail to make the right number of connections.
Towards new indicators of vulnerability to psychotic disorders
The decision-making processes of healthy subjects with sub-clinical psychotic episodes are altered in a way that is similar to what happens in subjects with schizophrenia.
Inflammation inhibitor blocks neurodevelopmental disorders in mouse model
Work published this week in the journal Proceedings of the National Academy of Sciences shows that an enzyme inhibitor developed by Professor Bruce Hammock and colleagues at UC Davis reduced inflammation in the brains of mice born to mothers with maternal immune activation.
Improved treatment for alcohol use disorders, chronic pain, mood disorders
A Purdue University team is making drug discoveries to support millions around the world dealing with alcohol use disorders, chronic pain and mood disorders.
Gene therapy for blood disorders
Delivering gene-regulating material to cells that live deep in our bone marrow and direct the formation of blood cells.
More Neurodevelopmental Disorders News and Neurodevelopmental Disorders Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab